AnteoTech Limited (ASX:ADO)
Australia
· Delayed Price · Currency is AUD 0.0070
-0.0010 (-12.50%)
Apr 24, 2025, 4:10 PM AEST
AnteoTech Revenue
AnteoTech had revenue of 3.15M AUD in the half year ending December 31, 2024, a decrease of -10.02%. This brings the company's revenue in the last twelve months to -545.39K, down -153.45% year-over-year. In the fiscal year ending June 30, 2024, AnteoTech had annual revenue of 460.40K with 25.89% growth.
Revenue (ttm)
-545.39K
Revenue Growth
-153.45%
P/S Ratio
-34.72
Revenue / Employee
-5.51K
Employees
99
Market Cap
18.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 460.40K | 94.67K | 25.89% |
| Jun 30, 2023 | 365.72K | -395.15K | -51.93% |
| Jun 30, 2022 | 760.88K | -137.19K | -15.28% |
| Jun 30, 2021 | 898.07K | -367.90K | -29.06% |
| Jun 30, 2020 | 1.27M | 989.65K | 358.16% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |
AnteoTech News
- 2 months ago - AnteoTech Ltd (ASX:ADO) (H1 2025) Earnings Call Highlights: Transition to Market-Driven Success - GuruFocus
- 2 months ago - Half Year 2025 Anteotech Ltd Earnings Call Transcript - GuruFocus